Psoriatic arthritis patients with enthesitis missing out

The current PBS eligibility rules are based on RA

Patients with psoriatic arthritis and enthesitis are missing the opportunity to improve their condition using biological disease-modifying anti-rheumatic drugs (bDMARDs), because of current PBS rules, a new study shows.

Fifty-three patients with psoriatic arthritis prescribed biologics for at least three months and presenting at the Southern Adelaide Local Health Network biologics clinic, were compared with 52 people with the disease, but not eligible for bDMARDs, recruited from two Adelaide hospital rheumatology outpatient departments.

Among 32 patients with